This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP will not be entertained. The Congressionally Directed Medical Research Programs (CDMRP) is conducting market research to assess commercial availability to provide junior and senior level scientific support to support the research management needs at CDMRP. In-line with the above goal, the CDMRP wishes to obtain information from commercial sources that possess the capability to provide junior and senior level personnel support for current and future research programs. The anticipated contractor support duties are attached. The CDMRP directs the management of a number of medical research programs, including breast, prostate, ovarian, kidney, and lung cancer, defense health, neurofibromatosis, tuberous sclerosis complex, autism, psychological health/traumatic brain injury, spinal cord injury research, bone marrow failure, multiple sclerosis, Alzheimer's, Parkinson's, medical imaging, medical informatics, behavioral health, medical simulators, mobile health applications, medical robotics, deployed health, and other medical research programs. CDMRP requires contractor personnel to assist in the management of these programs. The anticipated level of support is dependent upon annual program funding but it is estimated that over the entire period of performance, roughly 40-60 support personnel could be required. Two senior-level Science Officers in each of the five major research portfolio areas will be considered Key Personnel: Autoimmune and Genetic Disorders; Cancer; Cardiovascular and Respiratory Health; Infectious Diseases; Neurological and Psychological Health; and Tissue, Organ, and Orthopedic Injuries and Restorative/Rehabilitative Medicine. See Attached Sources Sought Notice for Response Instructions.
